In the BioHarmony Drug Report Database

"Preview" Icon

Bulevirtide

Hepcludex (bulevirtide) is a protein pharmaceutical. Bulevirtide was first approved as Hepcludex on 2020-07-31. It has been approved in Europe to treat chronic hepatitis d.

 

Trade Name

 

Hepcludex
 

Common Name

 

bulevirtide
 

ChEMBL ID

 

CHEMBL4297711
 

Indication

 

chronic hepatitis d
 

Drug Class

 

Peptides: antiviral peptides; antivirals

Image (chem structure or protein)

Bulevirtide structure rendering